Biovest initiates formal regulatory approval process for BiovaxID in Europe.
D019496:Cancer Vaccines / Q000627:therapeutic use*; D017277:Drug Approval; D005060:Europe; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*
D019496:Cancer Vaccines